ArticleHistochemistry and cell biology2026
Differential impact of bisphenol S on human arterial endothelial cells from healthy and type-2 diabetic donors: a high-content imaging study.
Article in Histochemistry and cell biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Endothelial dysfunction is a central mechanism linking type 2 diabetes (T2D) to cardiovascular complications, and environmental endocrine-disrupting chemicals may further perturb vascular homeostasis. Bisphenol S (BPS), widely used as a bisphenol A substitute, is increasingly detected in human and environmental samples, but its impact on endothelial morphology in the context of pre-existing metabolic disease remains poorly defined. Here, we used high-content imaging and Cell Painting to determine whether exposure to 0.1 µM BPS for 96 h induces distinct morphology-based responses in primary human arterial endothelial cells from healthy and T2D donors. Multiplex staining of DNA, RNA-rich regions, RER, Golgi/membrane structures, and mitochondria was combined with automated segmentation, multidimensional feature extraction, sparse partial least-squares discriminant analysis, and inferential statistics. Metabolic status was the main determinant of the endothelial morphology-based profile, clearly separating healthy and T2D-derived cells. In addition, BPS induced a pronounced multidimensional phenotypic shift in healthy endothelial cells, involving nuclear, mitochondrial, RNA-associated, and membrane/perinuclear descriptors. In contrast, T2D-derived cells retained a dominant disease-associated profile, with a less evident whole-cell response to BPS. However, selected RER-associated descriptors remained BPS-responsive, indicating that BPS can still modulate stress-related subcellular organization under diabetic conditions. These findings show that BPS perturbs endothelial morphology under exposure-relevant low-dose conditions but that baseline metabolic status strongly shapes the magnitude and compartmental distribution of this response. The study identifies the diabetic endothelial phenotype as a key modifier of BPS-induced cellular remodeling and supports Cell Painting as a sensitive strategy to resolve context-dependent endothelial responses to environmental pollutants.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.